Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson's disease

NPJ Parkinson's Disease
Per OdinFilip Bergquist

Abstract

Motor aspects of Parkinson's disease, such as fluctuations and dyskinesia, can be reliably evaluated using a variety of "wearable" technologies, but practical guidance on objective measurement (OM) and the optimum use of these devices is lacking. Therefore, as a first step, a panel of movement disorder specialists met to provide guidance on how OM could be assessed and incorporated into clinical guidelines. A key aspect of the incorporation of OM into the management of Parkinson's disease (PD) is defining cutoff values that separate "controlled" from "uncontrolled" symptoms that can be modified by therapy and that relate to an outcome that is relevant to the person with PD (such as quality of life). Defining cutoffs by consensus, which can be subsequently tested and refined, is the first step to optimizing OM in the management of PD. OM should be used by all clinicians that treat people with PD but the least experienced may find the most value, but this requires guidance from experts to allow non-experts to apply guidelines. While evidence is gained for devices that produce OM, expert opinion is needed to supplement the evidence base.

References

Feb 17, 1973·Lancet·J S Carman
Apr 1, 1973·Journal of Chronic Diseases·E Singer
Apr 7, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·A M KuopioU K Rinne
Aug 17, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·A SchragN Quinn
Dec 5, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·A SchragN Quinn
May 23, 2002·BMJ : British Medical Journal·Arthur A StoneMichael R Hufford
Nov 20, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·K R ChaudhuriC Trenkwalder
Feb 8, 2003·Parkinsonism & Related Disorders·T KeränenA Takala
May 17, 2003·Sleep·Sonia Ancoli-IsraelCharles P Pollak
Feb 19, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Mark StacyFabrizio Stocchi
Jul 23, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Katherine A GrossetDonald G Grosset
Aug 11, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Katherine A GrossetDonald G Grosset
Dec 6, 2005·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M PéchevisUNKNOWN Trial Study Group
Jul 18, 2006·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Scott D Grosse, Muin J Khoury
Sep 1, 2006·The New England Journal of Medicine·Günther DeuschlUNKNOWN German Parkinson Study Group, Neurostimulation Section
Dec 22, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Kirsti K MartikainenReijo J Marttila
Sep 14, 2007·Disability and Rehabilitation·T A ZesiewiczK L Sullivan
Dec 13, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Amit S KulkarniMark A Stacy
Jun 3, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Elin Bjelland ForsaaGuido Alves
Jan 13, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Joseph P GiuffridaDustin A Heldman
Jun 13, 2009·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Douglas G Altman
Jun 16, 2009·Lancet·Andrew J LeesTamas Revesz
Mar 25, 2010·European Neurology·Fabrizio StocchiJose A Obeso
Sep 28, 2010·The American Journal of Geriatric Pharmacotherapy·Marcy L TarrantsDongmu Zhang
Feb 12, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Bart PostUNKNOWN CARPA-study group
Feb 12, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Jasmine C MenantStephen R Lord
Oct 8, 2011·Journal of Neuroscience Methods·Thomas O MeraJoseph P Giuffrida
Nov 2, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Susan H FoxCristina Sampaio
Nov 11, 2011·CNS Neuroscience & Therapeutics·Spyridon Spyros Papapetropoulos
Nov 15, 2011·Brain : a Journal of Neurology·Isabel PareésMark J Edwards
Jan 18, 2012·Annals of Internal Medicine·Amir QaseemSteven Weinberger
Nov 21, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Marjolein A van der MarckMark Guttman
Sep 14, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Walter MaetzlerBastiaan R Bloem
Nov 28, 2013·Parkinsonism & Related Disorders·F StocchiUNKNOWN DEEP study group
Oct 2, 2014·Parkinsonism & Related Disorders·A RizosUNKNOWN EUROPAR and the IPDMDS non-Motor PD Study Group
Aug 9, 2015·Journal of Neural Transmission·Christiana OssigAlexander Storch
Aug 22, 2015·Aging Clinical and Experimental Research·Fulvio LauretaniMarcello Maggio
Sep 28, 2015·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Marc K WaltonUNKNOWN International Society for Pharmacoeconomics and Outcomes Research Task Force for Clinical Outcomes Assessment

❮ Previous
Next ❯

Citations

Jul 17, 2019·Der Nervenarzt·Jochen KluckenBjörn Eskofier
Oct 18, 2019·Expert Opinion on Drug Safety·Valentina LetaAngelo Antonini
Oct 12, 2019·NPJ Parkinson's Disease·Daniel J van WamelenK Ray Chaudhuri
Sep 3, 2020·Neurodegenerative Disease Management·Jason AldredK Ray Chaudhuri
Dec 7, 2018·Frontiers in Cellular Neuroscience·Khadija TayaraRocío M de Pablos
Nov 10, 2018·Journal of Parkinson's Disease·Anthony SantiagoCarrolee Barlow
Sep 17, 2020·Journal of Neurology·Parisa FarzanehfarMalcolm Horne
Apr 16, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·K Ray ChaudhuriAngelo Antonini
Feb 2, 2021·Journal of Parkinson's Disease·Daniel J van WamelenK Ray Chaudhuri
Dec 11, 2020·NPJ Parkinson's Disease·Holly WoodrowUNKNOWN Treat to Target Study Group
Nov 14, 2020·Movement Disorders : Official Journal of the Movement Disorder Society·David DevosRichard Wyse
May 29, 2020·Lancet Neurology·Angelo Antonini
Jul 18, 2021·Journal of Neuroengineering and Rehabilitation·Hamid KhodakaramiMalcolm Horne
Aug 8, 2021·Parkinsonism & Related Disorders·Daniel J van WamelenUNKNOWN International Parkinson and Movement Disorder Society Non Motor Parkinson's Disease Study Group
Nov 3, 2021·Biomedizinische Technik. Biomedical Engineering·Rene Peter BremmFrank Hertel

❮ Previous
Next ❯

Software Mentioned

Kinesia

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Parkinson's Disease
Anna Rosa CartaGilberto Fisone
Movement Disorders : Official Journal of the Movement Disorder Society
Álvaro Sánchez-Ferro, Walter Maetzler
Medicina, cirurgia, farmácia
A AKERMAN
Indian Journal of Psychiatry
J Ananth
© 2022 Meta ULC. All rights reserved